中华医学杂志
2020年 · 第100卷第28期
中华医学杂志
新型冠状病毒肺炎合并肾损伤的预防和诊治专家建议
The novel coronavirus pneumonia (COVID-19) is a newly discovered class of infectious diseases that have spread globally. COVID-19 is caused by infection with SARS-CoV-2, which infects cells with angiotensin-converting enzyme II (ACE2) as a receptor. COVID-19 is dominated by respiratory lesions, and can involve multiple systems and organs such as kidneys, liver, heart, and blood. This disease is mainly transmitted through respiratory droplets and direct contact. Aerosol transmission is possible in a closed environment, and feces and urine may cause environmental pollution. Its incubation period is generally 1~14 days (mostly 3~7 days). This disease is generally susceptible in the population, and chronic kidney disease (CKD), especially dialysis patients, are also potentially susceptible populations. 16% ~20% of COVID-19 patients are clinically critically ill. Kidney involvement is often manifested as acute kidney injury (AKI) and proteinuria, and the occurrence of kidney injury has an important impact on the prognosis of COVID-19 patients[
阻塞性睡眠呼吸暂停患者睡眠脑电慢波活动的特征
仰卧位相关型及快速眼动期相关型轻中度阻塞性睡眠呼吸暂停低通气综合征的临床特征
重度阻塞性睡眠呼吸暂停综合征患者脉氧下降率与日间嗜睡的相关性
Ⅲ型睡眠监测仪对慢性阻塞性肺疾病患者阻塞性睡眠呼吸暂停的诊断价值
同型半胱氨酸和血压波动对高血压合并阻塞性睡眠呼吸暂停低通气综合征患者的预测价值
宏基因二代测序技术检测多瘤病毒在尿路感染中的临床应用
家族性腺瘤性息肉病合并十二指肠腺瘤的诊疗分析
经尿道输尿管置入术和肾造瘘术在小婴儿重度肾积水治疗中的临床观察
吸气肌训练联合耐力训练对病毒性心肌炎心衰患者心肺耐力及外周肌力的影响
中国北方城市体检健康居民营养状况及微炎症状态的调查
Graves病胫前黏液性水肿的临床分析
第511例 意识障碍—精神行为异常—淋巴结肿大
贲门黏膜内癌合并胃肠道间质瘤一例
经胃内镜胰腺包裹性坏死开窗清创引流术一例
延髓精原细胞瘤致阻塞性睡眠呼吸暂停术后13年随访一例
机械力生物链内源性干细胞激活治疗勃起功能障碍的研究进展
肥胖是代谢相关性脂肪肝患者发生较严重COVID-19的危险因素
The World Health Organization declared novel coronavirus pneumonia (COVID-19) a pandemic in 2020. Patients with metabolism-related fatty liver disease (MAFLD) often have other metabolic risk factors such as obesity and hypertension that may exacerbate COVID-19. To explore the association between MAFLD and COVID-19 severity, the study continuously enrolled 214 COVID-19 patients aged 18 to 75 years, and the diagnosis was confirmed by high-throughput sequencing of oropharyngeal swab specimens or real-time reverse transcription PCR. According to the international expert consensus on MAFLD in 2020, and the included patients were screened for fatty liver by abdominal CT to diagnose the presence or absence of MAFLD. The study finally included 66 patients with MAFLD who were divided into obese groups based on the presence or absence of obesity (n=45) versus non-obese group (n=21)。 The enrolled patients were divided into severe and non-severe groups according to China's "Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial 7th Edition)", and received standard treatment. The results showed that compared with the non-obese group, patients in the obese group had higher levels of aspartate aminotransferase, lower fasting blood glucose, low-density lipoprotein, lymphocyte counts, and more severe COVID-19 (37.5% vs 9.5%,P=0.021)。 The results of logistic regression analysis showed that among patients with MAFLD, obese people had an approximately 6-fold increased risk of severe COVID-19 compared with non-obese people (OR=5.77,95%CI:1.19~27.91,P =0.029); Obesity remained independently associated with COVID-19 severity after adjusting for the confounders age, sex, smoking, diabetes, hypertension, and dyslipidemia (OR=6.32,95%CI:1.16~34.54,P=0.033)。
本期目次

